Canadian biotech startup Afynia Laboratories, a spin-out from McMaster University in Ontario, has picked up $5 million in seed funding to commercialize a blood test for endometriosis — a medical condition that can afflict people with a uterus, causing problems like chronic pelvic pain and fertility issues. Endometriosis affects nearly 200 million people worldwide. Getting […]
© 2024 TechCrunch. All rights reserved. For personal use only.
Hence then, the article about university spin out afynia secures 5m seed to commercialize its microrna panel test for endometriosis was published today ( ) and is available on tech crunch ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis )
Also on site :
- Union boss ‘held up Communist flag alongside people singing pro-Russia chants in occupied Ukraine’
- Large house fire near Buckeye Lake kills one, critically injures second victim
- 'Sister Wives' Meri Brown Opens Up About Family Finances After Consenting to ‘Never Talk’ About Kody Deal